Clinical trial

Evaluation of the HekaHeart Platform in Medication Management for Heart Failure Patients

NCT06433687

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention HekaHeart platform medication management and remote monitoring Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Evaluation of the HekaHeart Platform in Medication Management for Heart Failure Patients

Design: OBSERVATIONAL · Status: WITHDRAWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusWITHDRAWN

Study typeOBSERVATIONAL

Start date2025-10-01

PhaseN/A

Conditions

Heart Failure With Reduced Ejection Fractionunresolved

Interventions

HekaHeart platform medication management and remote monitoringDEVICE

Sponsors & collaborators

Yale Universitylead sponsor

HekaHeartcollaborator

Mapped research locations

New HavenConnecticut, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06433687 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.